2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3,3-diphenyl-4-[(4-carboxyl butyryl)oxy]butyric Acid

ID: ALA1798076

Chembl Id: CHEMBL1798076

PubChem CID: 56680048

Max Phase: Preclinical

Molecular Formula: C27H28N2O7

Molecular Weight: 492.53

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  Cc1cc(C)nc(OC(C(=O)O)C(COC(=O)CCCC(=O)O)(c2ccccc2)c2ccccc2)n1

Standard InChI:  InChI=1S/C27H28N2O7/c1-18-16-19(2)29-26(28-18)36-24(25(33)34)27(20-10-5-3-6-11-20,21-12-7-4-8-13-21)17-35-23(32)15-9-14-22(30)31/h3-8,10-13,16,24H,9,14-15,17H2,1-2H3,(H,30,31)(H,33,34)

Standard InChI Key:  ISAXECXKUOYCNQ-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA1798076

   5-[3-Carboxy-3-(4,6-dimethylpyrimidin-2-yl)oxy-2,2-diphenylpropoxy]-5-oxopentanoic acid

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 492.53

Molecular Weight (Monoisotopic): 492.1897

AlogP: 3.71

#Rotatable Bonds: 12

Polar Surface Area: 135.91

Molecular Species: ACID

HBA: 7

HBD: 2

#RO5 Violations: ┄

HBA (Lipinski): 9

HBD (Lipinski): 2

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 3.10

CX Basic pKa: 3.72

CX LogP: 2.99

CX LogD: -2.72

Aromatic Rings: 3

Heavy Atoms: 36

QED Weighted: 0.36

Np Likeness Score: -0.14

References

1. Xia J, Song J, Zhen L, Zhang X, Lei X, Zheng L, Wang Q, Sun H..  (2011)  Synthesis and in vitro evaluation of ambrisentan analogues as potential endothelin receptor antagonists.,  21  (13): [PMID:21652209] [10.1016/j.bmcl.2011.05.034]

Source

Source(1):

• Scientific Literature